Founded in 1998, the Swiss Biotech Association represents the interests of the Swiss biotech industry. To support its members in a competitive market, the Swiss Biotech Association works to secure favorable framework conditions and facilitate access to talents, novel technologies and financial resources. To strengthen and promote the Swiss biotech industry, the Swiss Biotech Association collaborates with numerous partners and life science clusters globally under the brand Swiss Biotech™.
3B Biotech is a Swiss based full service Contract Research Organization, Regulatory affairs and Pharmacovigilance specialist. Our solutions support pharma, biotech, medical and nutritional companies during the development, research, marketing and post-marketing programs.
4bases is a company active in the fields of prevention and precision medicine. 4bases is a certified company working accordingly to the IVDR regulation. Our products are reagent kits for platform-independent New Generation DNA Sequencing (NGS), data analysis software and diagnostic protocols.
4G Clinical is a global leader in randomisation and trial supply management and supply forecasting optimisation software for the life sciences industry, offering a fully cloud-based, 100% configurable solution using natural language processing to accelerate clinical trials.
7AlpsBio Consulting Services offers expertise in healthcare in strategic, operational, project support and a management know-how with a focus on ATMPs, biopharmaceuticals and life sciences in (pre)clinical development, GMP manufacturing from clinical trials to commercialization.
abc biopply humanized disease models predict patient response to treatment Our proprietary technology creates hundreds of miniature patient organs in a laboratory setting, using both healthy and diseased tissues. Our innovative models bridge the gap in predictability between the lab and the clinic.
Provides services in business development, strategy and product evaluation.
ABCDx is specialized in the discovery, clinical validation and commercialization of point-of-care diagnostics with advanced blood-based biomarkers for acute brain injuries such as trauma and stroke.
Abologix is a biopharmaceutical company and a spin-out from the laboratories of Prof. Beat Imhof and Prof. Thomas Matthes at the University of Geneva.